These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 3931288)

  • 1. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
    van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
    Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX.
    Mertens K; van Wijngaarden A; Bertina RM
    Thromb Haemost; 1985 Oct; 54(3):654-60. PubMed ID: 3937263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
    Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
    Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of phospholipid and factor VIIIa in the activation of bovine factor X.
    van Dieijen G; Tans G; Rosing J; Hemker HC
    J Biol Chem; 1981 Apr; 256(7):3433-42. PubMed ID: 6782101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of electrostatic interactions in the assembly of the factor X activating complex on both activated platelets and negatively-charged phospholipid vesicles.
    London F; Walsh PN
    Biochemistry; 1996 Sep; 35(37):12146-54. PubMed ID: 8810922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.
    London F; Ahmad SS; Walsh PN
    Biochemistry; 1996 Dec; 35(51):16886-97. PubMed ID: 8988028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
    Sheehan JP; Kobbervig CE; Kirkpatrick HM
    Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic comparison of bovine blood coagulation factors IXa alpha and IXa beta toward bovine factor X.
    Link RP; Castellino FJ
    Biochemistry; 1983 Aug; 22(17):4033-41. PubMed ID: 6412750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
    Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
    Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetic assembly of the intrinsic bovine factor X activation system.
    Beals JM; Chibber BA; Castellino FJ
    Arch Biochem Biophys; 1989 Feb; 268(2):485-501. PubMed ID: 2492418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
    Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI
    Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.
    Mertens K; Bertina RM
    Biochem J; 1984 Nov; 223(3):607-15. PubMed ID: 6334517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
    Wong MY; Gurr JA; Walsh PN
    Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa.
    Scandura JM; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8903-13. PubMed ID: 8688426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial activation of the factor VIIIa-factor IXa enzyme complex by dihexanoic phosphatidylserine at submicellar concentrations.
    Gilbert GE; Arena AA
    Biochemistry; 1997 Sep; 36(35):10768-76. PubMed ID: 9271508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.